Insmed, Inc. INSM
117.83
(3.72)
(3.06%)
as of 25 Sep
- Market cap
- $26.8B
- P/E
- 0.0×
Follow INSM
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (87.22%) | (294.46%) | (249.28%) | (165.69%) |
+8 more TTM periods Free account |
|
| (38.20%) | (61.04%) | (59.53%) | (53.64%) | ||
ROIC |
(329.22%) | (1,659.95%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(67.21%) | (87.36%) | (89.39%) | (73.79%) | |
Average Days of Receivables |
69.09 | 79.52 | 84.78 | 53.28 | |
Free Cash Flow per Share |
(3.72) | (4.28) | (4.86) | (4.28) | |
Free Cash Flow |
(807.67) | (921.63) | (967.57) | (906.14) | |
Capital Expenditures |
(28.75) | (25.97) | (32.56) | (22.74) | |
Piotroski F-Score |
4.00 | 5.00 | 4.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(31.41%) | (35.96%) | (34.24%) | (27.72%) | |
Accounts Receivable Turnover |
8.42 | 7.24 | 6.29 | 8.31 | |
Accounts Payable Turnover |
0.51 | 0.51 | 0.33 | 0.32 | |
Inventory Turnover |
1.51 | 1.28 | 1.07 | 0.96 | |
Average Days of Payables |
831.80 | 863.18 | 1,354.03 | 1,426.44 | |
Days of Inventory on Hand |
276.12 | 325.41 | 392.11 | 421.02 | |
Tax Rate |
0.01 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
75.67% | 101.03% | 127.15% | 155.68% | |
Selling, General and Administrative Expense of Revenue |
78.55% | 97.72% | 115.62% | 141.20% | |
Share Based Compensation of Revenue |
13.84% | 19.43% | 25.18% | 31.37% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.89 | 0.76 | 0.73 | 0.75 | |
Depreciation/Fixed assets |
0.26 | 0.26 | 0.25 | 0.26 | |
Capex/Depreciation |
(1.02) | (0.97) | (1.28) | (0.99) | |
Revenue per Share |
5.23 | 3.80 | 3.05 | 2.11 | |
Operating CF per Share |
(3.58) | (4.16) | (4.70) | (4.17) | |
Capex per Share |
(0.13) | (0.12) | (0.16) | (0.11) | |
Capex to Sales |
0.03 | 0.03 | 0.05 | 0.05 | |
Net Profit Margin |
(76.94%) | (144.44%) | (210.54%) | (264.83%) |
Columns are period end dates